These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10430331)

  • 21. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
    Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
    Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
    Vilien M; Dahlerup JF; Munck LK; Nørregaard P; Grønbaek K; Fallingborg J
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1147-52. PubMed ID: 15153167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
    Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C
    Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
    Oren R; Moshkowitz M; Odes S; Becker S; Keter D; Pomeranz I; Shirin H; Reisfeld I; Broide E; Lavy A; Fich A; Eliakim R; Patz J; Villa Y; Arber N; Gilat T
    Am J Gastroenterol; 1997 Dec; 92(12):2203-9. PubMed ID: 9399753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of levamisole on the prevention of developmental flare-ups in quiescent Crohn's disease: a prospective multicenter controlled trial in 155 patients].
    Modigliani R; Pieddeloup C; Hecketsweiler P; Descos L; Lerebours E; Vernisse B; Costil V; Bitoun A; Lacroute JM; Maire P
    Gastroenterol Clin Biol; 1983; 7(8-9):683-92. PubMed ID: 6352383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
    Sandborn WJ; Tremaine WJ; Lawson GM
    Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National Cooperative Crohn's Disease Study: results of drug treatment.
    Summers RW; Switz DM; Sessions JT; Becktel JM; Best WR; Kern F; Singleton JW
    Gastroenterology; 1979 Oct; 77(4 Pt 2):847-69. PubMed ID: 38176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
    Mowat C; Arnott I; Cahill A; Smith M; Ahmad T; Subramanian S; Travis S; Morris J; Hamlin J; Dhar A; Nwokolo C; Edwards C; Creed T; Bloom S; Yousif M; Thomas L; Campbell S; Lewis SJ; Sebastian S; Sen S; Lal S; Hawkey C; Murray C; Cummings F; Goh J; Lindsay JO; Arebi N; Potts L; McKinley AJ; Thomson JM; Todd JA; Collie M; Dunlop MG; Mowat A; Gaya DR; Winter J; Naismith GD; Ennis H; Keerie C; Lewis S; Prescott RJ; Kennedy NA; Satsangi J;
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):273-282. PubMed ID: 28404197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.
    Brynskov J; Freund L; Rasmussen SN; Lauritsen K; de Muckadell OS; Williams N; MacDonald AS; Tanton R; Molina F; Campanini MC
    N Engl J Med; 1989 Sep; 321(13):845-50. PubMed ID: 2671739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive drugs in Crohn's disease.
    Kornbluth A; George J; Sachar DB
    Gastroenterologist; 1994 Sep; 2(3):239-46. PubMed ID: 7987622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
    Sachar DB; Rubin KP; Gumaste V
    Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety and tolerability of methotrexate for treating patients with Crohn's disease.
    Chande N; Abdelgadir I; Gregor J
    J Clin Gastroenterol; 2011 Aug; 45(7):599-601. PubMed ID: 21224737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
    Suares NC; Hamlin PJ; Greer DP; Warren L; Clark T; Ford AC
    Aliment Pharmacol Ther; 2012 Jan; 35(2):284-91. PubMed ID: 22112005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease.
    Feagan BG; McDonald JW; Panaccione R; Enns RA; Bernstein CN; Ponich TP; Bourdages R; Macintosh DG; Dallaire C; Cohen A; Fedorak RN; Paré P; Bitton A; Saibil F; Anderson F; Donner A; Wong CJ; Zou G; Vandervoort MK; Hopkins M; Greenberg GR
    Gastroenterology; 2014 Mar; 146(3):681-688.e1. PubMed ID: 24269926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ornidazole in the treatment of active Crohn's disease: short-term results.
    Triantafillidis JK; Nicolakis D; Emmanoullidis A; Antoniou A; Papatheodorou K; Cheracakis P
    Ital J Gastroenterol; 1996 Jan; 28(1):10-4. PubMed ID: 8743067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A trial of sulfasalazine as adjunctive therapy in Crohn's disease.
    Singleton JW; Summers RW; Kern F; Becktel JM; Best WR; Hansen RN; Winship DH
    Gastroenterology; 1979 Oct; 77(4 Pt 2):887-97. PubMed ID: 38179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National Cooperative Crohn's Disease Study: study design and conduct of the study.
    Winship DH; Summers RW; Singleton JW; Best WR; Becktel JM; Lenk LF; Kern F
    Gastroenterology; 1979 Oct; 77(4 Pt 2):829-42. PubMed ID: 38175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus for Crohn's disease.
    Ruddock B
    Issues Emerg Health Technol; 2006 Sep; (88):1-4. PubMed ID: 16981314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.